Moore, Tamson http://orcid.org/0000-0003-3770-3503
Wagner, Courtney Regan
Scurti, Gina M.
Hutchens, Kelli A.
Godellas, Constantine
Clark, Ann Lau
Kolawole, Elizabeth Motunrayo
Hellman, Lance M.
Singh, Nishant K.
Huyke, Fernando A.
Wang, Siao-Yi
Calabrese, Kelly M.
Embree, Heather D.
Orentas, Rimas
Shirai, Keisuke
Dellacecca, Emilia
Garrett-Mayer, Elizabeth
Li, Mingli
Eby, Jonathan M.
Stiff, Patrick J.
Evavold, Brian D.
Baker, Brian M.
Le Poole, I. Caroline
Dropulic, Boro
Clark, Joseph I.
Nishimura, Michael I.
Funding for this research was provided by:
National Institutes of Health (R43 CA126461, R44 CA126461, R01 CA90873, R01 CA104947, R01 CA104947-S1, P01 CA154778, R01 AI129543-01, R01 AI129543-01, R01 AI096879, R01 AI129543-01)
Article History
Received: 4 March 2017
Accepted: 3 October 2017
First Online: 20 October 2017
Change Date: 20 December 2017
Change Type: Correction
Change Details: The authors would like to make the following corrections to the published article.
Compliance with ethical standards
:
: Author Joseph I. Clark received speaking honorariums from Merck and Bristol-Myers Squibb, and is an unpaid member of the steering committee for the Prometheus PROCLAIM high-dose IL-2 database. Other authors report no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.